We are live on
!
Find out more
SCS
Syquant Capital SAS Portfolio holdings
AUM
$447M
1-Year Est. Return
13.04%
This Fund
S&P 500
This Quarter
Est. Return
+20.11%
1 Year Est. Return
+13.04%
3 Year Est. Return
+175.6%
5 Year Est. Return
+350.63%
10 Year Est. Return
–
AUM
$141M
AUM Growth
+$70.5M
(+100%)
Cap. Flow
+$67.4M
Cap. Flow
% of AUM
47.83%
Top 10 Holdings %
Top 10 Hldgs %
98.66%
Holding
18
New
12
Increased
2
Reduced
–
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$33.2M |
| 2 |
ESGR
Enstar Group
ESGR
|
+$18.3M |
| 3 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$17.4M |
| 4 |
K
Kellanova
K
|
+$12M |
| 5 |
DESP
Despegar.com
DESP
|
+$8.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
+$18.6M |
| 2 |
SMAR
Smartsheet Inc.
SMAR
|
+$15.4M |
| 3 |
CON
Concentra Group Holdings
CON
|
+$1.46M |
| 4 |
Hafnia
HAFN
|
+$165K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 29.93% |
| 2 | Healthcare | 24.92% |
| 3 | Financials | 17.91% |
| 4 | Industrials | 15.08% |
| 5 | Consumer Discretionary | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
K
1
DELISTED
Kellanova
K
| $42.2M | 29.93% |
511,400
+145,900
| +40% | +$12M |
|
|
ITCI
2
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $35.1M | 24.92% |
+266,228
| New | +$33.2M |
|
|
ESGR
3
DELISTED
Enstar Group
ESGR
| $23.9M | 16.93% |
71,807
+55,365
| +337% | +$18.3M |
|
|
BECN
4
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $18.5M | 13.13% |
+149,581
| New | +$17.4M |
|
|
DESP
5
DELISTED
Despegar.com
DESP
| $8.41M | 5.97% |
+447,800
| New | +$8.6M |
|
|
PLYA
6
DELISTED
Playa Hotels & Resorts
PLYA
| $4.1M | 2.91% |
+307,458
| New | +$3.99M |
|
|
HEES
7
DELISTED
H&E Equipment Services
HEES
| $2.65M | 1.88% |
+28,000
| New | +$2.44M |
|
8
Applovin
APP
$143B
| $1.84M | 1.3% |
+6,929
| New | +$2.39M |
|
|
AMPS
9
DELISTED
Altus Power
AMPS
| $1.26M | 0.9% |
+255,000
| New | +$1.16M |
|
|
PYCR
10
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $1.12M | 0.8% |
+50,000
| New | +$1.11M |
|
11
Coinbase
COIN
$41.4B
| $930K | 0.66% |
+5,398
| New | +$1.31M |
|
12
Robinhood
HOOD
$89.7B
| $445K | 0.32% |
+10,700
| New | +$509K |
|
13
Reddit
RDDT
$34.9B
| $413K | 0.29% |
+3,940
| New | +$651K |
|
|
DM
14
DELISTED
Desktop Metal, Inc.
DM
| $103K | 0.07% |
+20,900
| New | +$54.1K |
|
|
15
Hafnia
HAFN
$3.62B
| – | – |
-30,865
| Closed | -$165K |
|
|
CON
16
Concentra Group Holdings
CON
$4.04B
| – | – |
-73,893
| Closed | -$1.46M |
|
|
HCP
17
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| – | – |
-542,344
| Closed | -$18.6M |
|
|
SMAR
18
DELISTED
Smartsheet Inc.
SMAR
| – | – |
-275,349
| Closed | -$15.4M |
|
Similar funds
PT
FFO
PC
AIS
SCA
FTA
GC
POEH
Syquant Capital SAS's Q1 2025 Portfolio in Review
As of Q1 2025, Syquant Capital SAS held 18 positions worth $141M, up 100% from $70.5M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Syquant Capital SAS deployed $67.4M of net new capital in Q1 2025, opening 12 new positions and adding to 2 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 266,228 shares worth $35.1M.
By sector, the portfolio is most concentrated in Consumer Staples at 30% of assets, down from 42% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the most notable exit was HashiCorp, Inc. Class A Common Stock, an estimated $18.6M sold.
- Syquant Capital SAS's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 266,228 shares worth $35.1M.
- Syquant Capital SAS added most to Enstar Group in Q1 2025, an estimated $18.3M increase.
- Syquant Capital SAS fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $18.6M.
- Syquant Capital SAS's ten largest holdings make up 99% of its $141M portfolio in Q1 2025.
- Syquant Capital SAS opened 12 new positions and closed 4 in Q1 2025.
- Syquant Capital SAS's portfolio value rose 100% quarter-over-quarter to $141M.
Based on Syquant Capital SAS's 13F filing for Q1 2025, filed 23 Apr 2025.